Bryan Glaser, PhD
Position title: Senior Vice President of Business Development, Invenra, Inc. Madison, WI
Email: btglaser@hotmail.com
Phone: Advisor: Dr. Richard Burgess
Address:
Graduation: 09/2008
Research Interest: Biotechnology
Alumni News
- Specialties: Protein Purification, Assay Development, High Throughput Screening, Drug Characterization, Infectious Diseases, Cancer Research, Molecular Biology
Publications
- Tambo-ong A, Chopra S, Glaser BT, Matsuyama K, Tran T, and Madrid PB (2011). Mannich reaction derivatives of novobiocin with modulated physiochemical properties and their antibacterial activities. Bioorg Med Chem Lett. 21:5697-700. PMCID: PMC3178263
- Glaser BT, Malerich JP, Duellman SJ, Fong J, Hutson C, Fine RM, Keblansky B, Tang MJ, and Madrid PB (2011). A high-throughput fluorescence polarization assay for inhibitors of gyrase. J Biomol Screen. 16:230-238. PMCID: PMC3176662
- Glaser BT, Bergendahl V, Anthony LC, Olson B, and Burgess RR (2009.) Studying the salt dependence of the binding of sigma70 and sigma32 to core RNA polymerase using luminescence resonance energy transfer. PLoS One.4:e6490. PMCID: PMC2715106
- Thompson NE, Glaser BT, Foley KM, Burton ZF, and Burgess RR (2009).Minimal promoter systems reveal the importance of conserved residues in the B-finger of human transcription factor IIB. J Biol Chem. 284:24754-2466. Epub 2009 Jul 9. PMCID: PMC2757179
- Glaser BT, Bergendahl V, Thompson NE, and Burgess RR (2007). LRET-Based High-Throughput Screening of a Small-Compound Library for Inhibitors of Bacterial RNA Polymerase. Assay Drug Dev. Technol. 5:759-768. PMID:18052851
- Bergendahl V, Glaser BT, and Burgess RR (2003). A fast Western blot procedure improved for quantitative analysis by direct fluorescence labeling of primary antibodies. J Immunol Methods. 277:117-125. PMID:12799044